Ampio Pharmaceuticals
AMPE
$0.24
Share price
9.82%
Change (1 day)
-13.71%
Change (1 year)
Categories
Ampio Pharmaceuticals (AMPE) - P/B ratio
P/B ratio as of May 2024 : 0.0743
According to Ampio Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.0743.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ampio Pharmaceuticals - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.5076 | 76.15% |
| 2022-12-31 | 0.2882 | -93.93% |
| 2021-12-31 | 4.75 | -71.76% |
| 2020-12-31 | 16.8 | 17.05% |
| 2019-12-31 | 14.4 | 71.61% |
| 2018-12-31 | 8.37 | -192.5% |
| 2017-12-31 | -9.04 | -216.56% |
| 2016-12-31 | 7.76 | 61.69% |
| 2015-12-31 | 4.80 | 76.2% |
| 2014-12-31 | 2.72 | -69.84% |
| 2013-12-31 | 9.03 | 61.95% |
| 2012-12-31 | 5.58 | -19.49% |
| 2011-12-31 | 6.93 | -167.61% |
| 2010-12-31 | -10.2 | 96.81% |
| 2009-12-31 | -5.20 | -83.63% |
| 2008-12-31 | -31.8 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.30 | 7,033.28% | 🇺🇸 USA |
 Pfizer PFE | 1.84 | 2,368.93% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.70 | 6,220.59% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 3.95 | 5,215.64% | 🇺🇸 USA |
 Rigel Pharmaceuticals RIGL | -6.02 | -8,193.32% | 🇺🇸 USA |